Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression

Tumor Biology

Volumn 36, Issue 12, 2015, Pages 9311-9317

  Deng, Biyong ^a   Qiu, Bing ^a  

^a Guizhou Province Osteological Hospital   (China)

Author keywords

Matrix metalloproteinase (MMP) 13; Osteosarcoma (OS); Shikonin

Indexed keywords

COLLAGENASE 3; SHIKONIN; NAPHTHOQUINONE;

ANALYSIS OF VARIANCE; ARTICLE; BIOTINYLATION; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; HUMAN; HUMAN CELL; LOW DRUG DOSE; METASTASIS; OSTEOSARCOMA; PLASMID; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR INVASION; APOPTOSIS; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 13; NAPHTHOQUINONES; NEOPLASM INVASIVENESS; OSTEOSARCOMA;

EID: 84952874054     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3662-1     Document Type: Article

References (38)

1. Tsuchiya H, Tomita K, Mori Y, Asada N, Morinaga T, Kitano S, et al. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res. 1998;18:657–66.
2. Yang J, Zhang W. New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol. 2013;25:398–406.
3. Li G, Fu D, Liang W, Fan L, Chen K, Shan L, et al. Cyc1 silencing sensitizes osteosarcoma cells to trail-induced apoptosis. Cell Physiol Biochem. 2014;34:2070–80.
4. Liu Y, He J, Chen X, Li J, Shen M, Yu W, et al. The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of erk and akt pathways. Cell Physiol Biochem. 2014;34:637–45.
5. Wang Q, Cai J, Wang J, Xiong C, Zhao J. Mir-143 inhibits EGFR-signaling-dependent osteosarcoma invasion. Tumour Biol. 2014;35:12743–8.
6. Xiao Q, Zhang X, Wu Y, Yang Y. Inhibition of macrophage polarization prohibits growth of human osteosarcoma. Tumour Biol. 2014;35:7611–6.
7. Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M, Quan ZX, et al. Microrna-212 inhibits osteosarcoma cells proliferation and invasion by down-regulation of sox4. Cell Physiol Biochem. 2014;34:2180–8.
8. Li F, Li S, Cheng T. Tgf-beta1 promotes osteosarcoma cell migration and invasion through the mir-143-versican pathway. Cell Physiol Biochem. 2014;34:2169–79.
9. He Y, Meng C, Shao Z, Wang H, Yang S. Mir-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem. 2014;34:1485–96.
10. Chen J, Fu H, Wang Z, Yin F, Li J, Hua Y, et al. A new synthetic ursolic acid derivative iua with anti-tumor efficacy against osteosarcoma cells via inhibition of JNK signaling pathway. Cell Physiol Biochem. 2014;34:724–33.
11. Xu H, Liu X, Zhao J. Down-regulation of mir-3928 promoted osteosarcoma growth. Cell Physiol Biochem. 2014;33:1547–56.
12. Xu G, Wang J, Jia Y, Shen F, Han W, Kang Y. Mir-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting hmga1. Cell Physiol Biochem. 2014;33:1329–39.
13. Pan W, Wang H, Jianwei R, Ye Z. Microrna-27a promotes proliferation, migration and invasion by targeting map2k4 in human osteosarcoma cells. Cell Physiol Biochem. 2014;33:402–12.
14. Chen X, Luther G, Zhang W, Nan G, Wagner ER, Liao Z, et al. The e-f hand calcium-binding protein s100a4 regulates the proliferation, survival and differentiation potential of human osteosarcoma cells. Cell Physiol Biochem. 2013;32:1083–96.
15. Chang YW, Zhao YF, Cao YL, Gu XF, Li ZQ, Wang SQ, et al. Liver x receptor alpha inhibits osteosarcoma cell proliferation through up-regulation of foxo1. Cell Physiol Biochem. 2013;32:180–6.
16. Demuth T, Berens ME. Molecular mechanisms of glioma cell migration and invasion. J Neurooncol. 2004;70:217–28.
17. Shang HS, Chang JB, Lin JH, Lin JP, Hsu SC, Liu CM, et al. Deguelin inhibits the migration and invasion of u-2 os human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro. Molecules. 2014;19:16588–608.
18. Chueh FS, Chen YY, Huang AC, Ho HC, Liao CL, Yang JS, et al. Bufalin-inhibited migration and invasion in human osteosarcoma u-2 os cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol. 2014;29:21–9.
19. Yang GF, Li XH, Zhao Z, Wang WB. Arsenic trioxide up-regulates fas expression in human osteosarcoma cells. Chin Med J (Engl). 2010;123:1768–73.
20. Zhou X, Yuan B, Yuan W, Wang C, Gao R, Wang J. The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma. Tumour Biol. 2014;35:6539–47.
21. Zhai M, Cong L, Han Y, Tu G. Cip2a is overexpressed in osteosarcoma and regulates cell proliferation and invasion. Tumour Biol. 2014;35:1123–8.
22. Meng Q, Zhao J, Liu H, Zhou G, Zhang W, Xu X, et al. Hmgb1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma. Tumour Biol. 2014;35:12265–74.
23. Li H, Zhang K, Liu LH, Ouyang Y, Bu J, Guo HB, et al. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma. Tumour Biol. 2014;35:5487–91.
24. Jianwei Z, Fan L, Xiancheng L, Enzhong B, Shuai L, Can L. Microrna 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol. 2013;34:3331–7.
25. Jianwei Z, Enzhong B, Fan L, Jian L, Ning A. Effects of kruppel-like factor 6 on osteosarcoma cell biological behavior. Tumour Biol. 2013;34:1097–105.
26. Futamura N, Nishida Y, Urakawa H, Kozawa E, Ikuta K, Hamada S, et al. Emmprin co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma. Tumour Biol. 2014;35:5159–65.
27. Ryu B, Li Y, Qian ZJ, Kim MM, Kim SK. Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to Cox-2, iNOS, MMPS, and MAPK signaling: implication for chronic articular disease. Chem Biol Interact. 2009;179:192–201.
28. Zhou Y, Hu Z, Li N, Jiang R. Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression. Int J Mol Med. 2015;35:1729–33.
29. Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther. 2011;19:1123–30.
30. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, et al. Autonomous regulation of osteosarcoma cell invasiveness by wnt5a/ror2 signaling. Oncogene. 2009;28:3197–208.
31. Ma O, Cai WW, Zender L, Dayaram T, Shen J, Herron AJ, et al. Mmp13, birc2 (ciap1), and birc3 (ciap2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res. 2009;69:2559–67.
32. Andujar I, Rios JL, Giner RM, Recio MC. Pharmacological properties of shikonin—a review of literature since 2002. Planta Med. 2013;79:1685–97.
33. Andujar I, Recio MC, Giner RM, Rios JL. Traditional Chinese medicine remedy to jury: the pharmacological basis for the use of shikonin as an anticancer therapy. Curr Med Chem. 2013;20:2892–8.
34. Wang R, Yin R, Zhou W, Xu D, Li S. Shikonin and its derivatives: a patent review. Expert Opin Ther Pat. 2012;22:977–97.
35. Fu Z, Deng B, Liao Y, Shan L, Yin F, Wang Z, et al. The anti-tumor effect of shikonin on osteosarcoma by inducing rip1 and rip3 dependent necroptosis. BMC Cancer. 2013;13:580.
36. Ponten J, Saksela E. Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer. 1967;2:434–47.
37. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2:329–33.
38. Inoue A, Takahashi H, Harada H, Kohno S, Ohue S, Kobayashi K, et al. Cancer stem-like cells of glioblastoma characteristically express mmp-13 and display highly invasive activity. Int J Oncol. 2010;37:1121–31.